Aims and Scope SLAS Technology reveals how scientists adapt technological advancements for life sciences exploration and experimentation in biomedical research and development. The journal emphasizes scientifi c and technical advances that enable and improve: • Life sciences research and development • Drug delivery • Diagnostics • Biomedical and molecular imaging • Personalized and precision medicine SLAS Technology’s Editorial Scope includes: the latest news in high-throughput and other laboratory automation technologies; micro/nanotechnologies, analytical, separation and quantitative techniques; synthetic chemistry and biology; informatics (data analysis, statistics, bio genomic and chemoinformatics). SLAS Technology is of particular interest to those involved in automation, bioengineering, micro- and nanotechnology, nanomedicine, microfl uidics, 3D printing, biotechnology, bioinformatics, analytical chemistry, biomedical optics, information technology, artifi cial intelligence, spectroscopy, clinical diagnostics, pharmacogenomics, molecular biology and biomedical sciences. Publication Information: SLAS Technology (ISSN 2472-6311). For 2023, volumes 28 (1-6 issues) are scheduled for publication. Further information is available on this journal and other Elsevier products through Elsevier’s website (https://www.elsevier.com). Back issues: Back issues of all previously published volumes are available direct from Elsevier Offi ces (Oxford and New York). Complete volumes and single issues can be purchased for 1997–2003. Earlier issues are available in high quality photo-duplicated copies as complete volumes only. Back volumes on microfi lm are available from UMI, 300 North Zeeb Road, Ann Arbor, MI 48106, USA. Orders, claims, and journal inquiries: Please contact the Elsevier Customer Service Department nearest you: St. Louis: Elsevier Customer Service Department, 3251 Riverport Lane, Maryland Heights, MO 63043, USA; phone: (877) 8397126 [toll free within the USA]; (+1) (314) 4478878 [outside the USA]; fax: (+1) (314) 4478077; e-mail: JournalCustomerService-usa@elsevier.com Oxford: Elsevier Customer Service Department, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, UK; phone: (+44) (1865) 843434; fax: (+44) (1865) 843970; e-mail: JournalsCustomerServiceEMEA@elsevier.com Tokyo: Elsevier Customer Service Department, 4F Higashi-Azabu, 1-Chome Bldg, 1-9-15 Higashi-Azabu, Minato-ku, Tokyo 106-0044, Japan; phone: (+81) (3) 5561 5037; fax: (+81) (3) 5561 5047; e-mail: JournalsCustomerServiceJapan@elsevier.com The Philippines: Elsevier Customer Service Department, 2nd Floor, Building H, UP-Ayalaland Technohub, Commonwealth Avenue, Diliman, Quezon City, Philippines 1101; phone: (+65) 63490222; fax: (+63) 23521394; e-mail: JournalsCustomerServiceAPAC@elsevier.com Language (usage and editing services): Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientifi c English may wish to use the English Language Editing service available from Elsevier’s Author Services at https://webshop.elsevier.com/language-editing-services/ language-editing/ or visit our customer support site https://service.elsevier. com for more information. Advertising information: If you are interested in advertising or other commercial opportunities please e-mail Commercialsales@elsevier.com and your inquiry will be passed to the correct person who will respond to you within 48 hours. Note to contributors: Online submission is now available for this journal, to submit your article online, go to https://www.editorialmanager.com/slastech. © 2023 Published by Elsevier Inc. on behalf of Society for Laboratory Automation and Screening. This journal and the individual contributions contained in it are protected under copyright, and the following terms and conditions apply to their use in addition to the terms of any Creative Commons or other user license that has been applied by the publisher to an individual article: Photocopying: Single photocopies of single articles may be made for personal use as allowed by national copyright laws. Permission is not required for photocopying of articles published under the CC BY license nor for photocopying for non-commercial purposes in accordance with any other user license applied by the publisher. Permission of the publisher and payment of a fee is required for all other photocopying, including multiple or systematic copying, copying for advertising or promotional purposes, resale, and all forms of document delivery. Special rates are available for educational institutions that wish to make photocopies for non-profi t educational classroom use. Derivative Works: Users may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions or companies. Other than for articles published under the CC BY license, permission of the publisher is required for resale or distribution outside the subscribing institution or company. For any subscribed articles or articles published under a CC BY-NC-ND license, permission of the publisher is required for all other derivative works, including compilations and translations. Storage or Usage: Except as outlined above or as set out in the relevant user license, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Permissions: For information on how to seek permission visit www.elsevier.com/permissions or call: (+44) 1865 843830 (UK) / (+1) 215 239 3804 (USA). Notice: No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, independent verifi cation of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer. Funding Body Agreements and Policies: Elsevier has established agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specifi ed as conditions of their grant awards. To learn more about existing agreements and policies please visit https://www.elsevier.com/fundingbodies Author Inquiries: You can track your submitted article at https://www. elsevier.com/track-submission. You can track your accepted article at https:// www.elsevier.com/trackarticle. You are also welcome to contact Customer Support via https://service.elsevier.com. The paper used in this publication meets the requirements of ANSI/NISO Z39.48-1992 (Permanence of Paper) Printed by CB Printforce Nederland B.V., Textielweg 12, Culemborg, NL For a full and complete Guide for Authors, please go to: https://slas-technology.org/
RkJQdWJsaXNoZXIy MTk3NTQxMg==